{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T19:02:08Z","timestamp":1782327728859,"version":"3.54.5"},"reference-count":71,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL115141"],"award-info":[{"award-number":["HL115141"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL134849"],"award-info":[{"award-number":["HL134849"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL148207"],"award-info":[{"award-number":["HL148207"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL148355"],"award-info":[{"award-number":["HL148355"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL153356"],"award-info":[{"award-number":["HL153356"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18SFRN33900144"],"award-info":[{"award-number":["18SFRN33900144"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["20SFRN35200163"],"award-info":[{"award-number":["20SFRN35200163"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.tcm.2022.01.004","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T01:51:56Z","timestamp":1642384316000},"page":"195-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["MicroRNA-mediated control of myocardial infarction in diabetes"],"prefix":"10.1016","volume":"33","author":[{"given":"Daniel","family":"P\u00e9rez-Cremades","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingshu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel","family":"Assa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Feinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.tcm.2022.01.004_bib0001","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Rao Kondapally Seshasai","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.004_bib0002","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovascular diabetology"},{"issue":"4","key":"10.1016\/j.tcm.2022.01.004_bib0003","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.004_bib0004","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.tcm.2022.01.004_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/484696","article-title":"MicroRNAs in insulin resistance and obesity","volume":"2012","author":"Williams","year":"2012","journal-title":"Experimental diabetes research"},{"issue":"4","key":"10.1016\/j.tcm.2022.01.004_bib0006","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/cvr\/cvr300","article-title":"Role of microRNAs in diabetes and its cardiovascular complications","volume":"93","author":"Shantikumar","year":"2012","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1016\/j.tcm.2022.01.004_bib0007","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2337\/db11-0952","article-title":"MicroRNA dysregulation in diabetic ischemic heart failure patients","volume":"61","author":"Greco","year":"2012","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.tcm.2022.01.004_bib0008","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.RES.87.12.1123","article-title":"Myocardial cell death in human diabetes","volume":"87","author":"Frustaci","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2022.01.004_bib0009","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fphar.2020.00042","article-title":"Distinct types of cell death and the implication in diabetic cardiomyopathy","volume":"11","author":"Chen","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.tcm.2022.01.004_bib0010","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3389\/fphar.2019.00551","article-title":"The role of autophagy in acute myocardial infarction","volume":"10","author":"Wu","year":"2019","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.tcm.2022.01.004_bib0011","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0022-2828(03)00113-5","article-title":"Targeted deletion of caspase-1 reduces early mortality and left ventricular dilatation following myocardial infarction","volume":"35","author":"Frantz","year":"2003","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.004_bib0012","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12933-018-0767-z","article-title":"MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin","volume":"17","author":"Dai","year":"2018","journal-title":"Cardiovascular diabetology"},{"issue":"7","key":"10.1016\/j.tcm.2022.01.004_bib0013","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/CIRCRESAHA.109.196329","article-title":"Gelsolin and cardiac myocyte apoptosis: a new target in the treatment of postinfarction remodeling","volume":"104","author":"Nishio","year":"2009","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.tcm.2022.01.004_bib0014","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/cvr\/cvq082","article-title":"Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia\/reperfusion injury via anti-apoptosis through its target PDCD4","volume":"87","author":"Cheng","year":"2010","journal-title":"Cardiovasc Res"},{"issue":"10","key":"10.1016\/j.tcm.2022.01.004_bib0015","doi-asserted-by":"crossref","first-page":"e75872","DOI":"10.1371\/journal.pone.0075872","article-title":"Ischemic postconditioning-mediated miRNA-21 protects against cardiac ischemia\/reperfusion injury via PTEN\/Akt pathway","volume":"8","author":"Tu","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.tcm.2022.01.004_bib0016","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.biocel.2009.03.002","article-title":"MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease","volume":"42","author":"Townley-Tilson","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"10.1016\/j.tcm.2022.01.004_bib0017","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1161\/CIRCGENETICS.110.958975","article-title":"Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage","volume":"4","author":"Kuwabara","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"issue":"3","key":"10.1016\/j.tcm.2022.01.004_bib0018","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s12013-013-9672-y","article-title":"Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1","volume":"67","author":"Yildirim","year":"2013","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.tcm.2022.01.004_bib0019","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3389\/fphys.2018.01275","article-title":"MiR-133a mimic alleviates T1DM-induced systolic dysfunction in Akita: an MRI-based study","volume":"9","author":"Nandi","year":"2018","journal-title":"Front Physiol"},{"issue":"1-2","key":"10.1016\/j.tcm.2022.01.004_bib0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11010-014-2273-2","article-title":"miR-133a mediates the hypoxia-induced apoptosis by inhibiting TAGLN2 expression in cardiac myocytes","volume":"400","author":"Li","year":"2015","journal-title":"Mol Cell Biochem"},{"issue":"11","key":"10.1016\/j.tcm.2022.01.004_bib0021","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1002\/jcb.29663","article-title":"MicroRNA-1 facilitates hypoxia-induced injury by targeting NOTCH3","volume":"121","author":"Xu","year":"2020","journal-title":"J Cell Biochem"},{"issue":"4","key":"10.1016\/j.tcm.2022.01.004_bib0022","first-page":"683","article-title":"Induction of autophagy markers is associated with attenuation of miR-133a in diabetic heart failure patients undergoing mechanical unloading","volume":"7","author":"Nandi","year":"2015","journal-title":"Am J Transl Res"},{"issue":"16","key":"10.1016\/j.tcm.2022.01.004_bib0023","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1016\/j.febslet.2010.07.027","article-title":"miR-1\/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes","volume":"584","author":"Shan","year":"2010","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.004_bib0024","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41598-017-00070-6","article-title":"Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes","volume":"7","author":"de Gonzalo-Calvo","year":"2017","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.tcm.2022.01.004_bib0025","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/CIRCRESAHA.112.300658","article-title":"mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts","volume":"112","author":"Chen","year":"2013","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.004_bib0026","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/CIRCRESAHA.115.307408","article-title":"VEGF-induced expression of miR-17-92 cluster in endothelial cells is mediated by ERK\/ELK1 activation and regulates angiogenesis","volume":"118","author":"Chamorro-Jorganes","year":"2016","journal-title":"Circ Res"},{"issue":"13","key":"10.1016\/j.tcm.2022.01.004_bib0027","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/cvr\/cvz315","article-title":"STAT3-miR-17\/20 signalling axis plays a critical role in attenuating myocardial infarction following rapamycin treatment in diabetic mice","volume":"116","author":"Samidurai","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"12","key":"10.1016\/j.tcm.2022.01.004_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101863","article-title":"Differential regulation of mTOR complexes with miR-302a attenuates myocardial reperfusion injury in diabetes","volume":"23","author":"Samidurai","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.tcm.2022.01.004_bib0029","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41551-017-0157-y","article-title":"Local and sustained miRNA delivery from an injectable hydrogel promotes cardiomyocyte proliferation and functional regeneration after ischemic injury","volume":"1","author":"Wang","year":"2017","journal-title":"Nat Biomed Eng"},{"issue":"3","key":"10.1016\/j.tcm.2022.01.004_bib0030","first-page":"350","article-title":"Diabetes exacerbates myocardial ischemia\/reperfusion injury by down-regulation of MicroRNA and up-regulation of O-GlcNAcylation","volume":"3","author":"Wang","year":"2018","journal-title":"JACC Basic Trans Sci"},{"issue":"3","key":"10.1016\/j.tcm.2022.01.004_bib0031","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1084\/jem.20101547","article-title":"miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes","volume":"208","author":"Qian","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.tcm.2022.01.004_bib0032","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.omtn.2018.12.010","article-title":"AntagomiR-103 and -107 treatment affects cardiac function and metabolism","volume":"14","author":"Rech","year":"2019","journal-title":"Molecul Ther Nucl Acid"},{"issue":"4","key":"10.1016\/j.tcm.2022.01.004_bib0033","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCRESAHA.117.305781","article-title":"MicroRNA-103\/107 regulate programmed necrosis and myocardial ischemia\/reperfusion injury through targeting FADD","volume":"117","author":"Wang","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2022.01.004_bib0034","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.freeradbiomed.2015.11.031","article-title":"MicroRNA-2861 regulates programmed necrosis in cardiomyocyte by impairing adenine nucleotide translocase 1 expression","volume":"91","author":"Wang","year":"2016","journal-title":"Free Radical Biol Med"},{"issue":"2","key":"10.1016\/j.tcm.2022.01.004_bib0035","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1113\/expphysiol.2008.044800","article-title":"Myocardial overexpression of adenine nucleotide translocase 1 ameliorates diabetic cardiomyopathy in mice","volume":"94","author":"Wang","year":"2009","journal-title":"Exp Physiol"},{"issue":"10","key":"10.1016\/j.tcm.2022.01.004_bib0036","doi-asserted-by":"crossref","first-page":"e1479","DOI":"10.1038\/cddis.2014.430","article-title":"MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy","volume":"5","author":"Li","year":"2014","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.004_bib0037","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIRCRESAHA.120.317244","article-title":"Mir-30d regulates cardiac remodeling by intracellular and paracrine signaling","volume":"128","author":"Li","year":"2021","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.tcm.2022.01.004_bib0038","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41419-018-0805-5","article-title":"MicroRNA-21 prevents excessive inflammation and cardiac dysfunction after myocardial infarction through targeting KBTBD7","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.004_bib0039","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/s12967-021-03142-4","article-title":"MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS","volume":"19","author":"Barutta","year":"2021","journal-title":"J Transl Med"},{"key":"10.1016\/j.tcm.2022.01.004_bib0040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.yjmcc.2017.03.002","article-title":"miR-146a mediates inflammatory changes and fibrosis in the heart in diabetes","volume":"105","author":"Feng","year":"2017","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"10.1016\/j.tcm.2022.01.004_bib0041","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/SHK.0000000000000604","article-title":"MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response","volume":"46","author":"Essandoh","year":"2016","journal-title":"Shock (Augusta, Ga)"},{"key":"10.1016\/j.tcm.2022.01.004_bib0042","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3389\/fimmu.2020.00625","article-title":"MicroRNA-155 implication in M1 polarization and the impact in inflammatory diseases","volume":"11","author":"Pasca","year":"2020","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.tcm.2022.01.004_bib0043","doi-asserted-by":"crossref","first-page":"e60161","DOI":"10.1371\/journal.pone.0060161","article-title":"Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts","volume":"8","author":"Kishore","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tcm.2022.01.004_bib0044","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.2147\/IJN.S138400","article-title":"Gold nanoparticle-based miR155 antagonist macrophage delivery restores the cardiac function in ovariectomized diabetic mouse model","volume":"12","author":"Jia","year":"2017","journal-title":"Int J Nanomed"},{"issue":"9","key":"10.1016\/j.tcm.2022.01.004_bib0045","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.2337\/diabetes.53.9.2383","article-title":"Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes","volume":"53","author":"Marfella","year":"2004","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.tcm.2022.01.004_bib0046","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1210\/er.2016-1122","article-title":"Emerging roles for MicroRNAs in diabetic microvascular disease: novel targets for therapy","volume":"38","author":"Zhang","year":"2017","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.004_bib0047","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/cvr\/cvw235","article-title":"Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy","volume":"113","author":"Rawal","year":"2017","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.004_bib0048","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/blood-2012-01-407106","article-title":"AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics","volume":"121","author":"Mocharla","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.004_bib0049","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yjmcc.2012.04.003","article-title":"Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1","volume":"53","author":"Meng","year":"2012","journal-title":"J Mol Cell Cardiol"},{"issue":"8","key":"10.1016\/j.tcm.2022.01.004_bib0050","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s00125-015-3622-8","article-title":"Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL\/6 mice","volume":"58","author":"Zheng","year":"2015","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.tcm.2022.01.004_bib0051","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.yexcr.2019.04.039","article-title":"Glucose impairs angiogenesis and promotes ventricular remodelling following myocardial infarction via upregulation of microRNA-17","volume":"381","author":"Yan","year":"2019","journal-title":"Exp Cell Res"},{"issue":"21","key":"10.1016\/j.tcm.2022.01.004_bib0052","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1152\/physiolgenomics.00020.2014","article-title":"miR-21 in ischemia\/reperfusion injury: a double-edged sword?","volume":"46","author":"Xu","year":"2014","journal-title":"Physiol Genomics"},{"issue":"7224","key":"10.1016\/j.tcm.2022.01.004_bib0053","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.tcm.2022.01.004_bib0054","first-page":"1689","article-title":"Micro-RNA 21Targets dual specific phosphatase 8 to promote collagen synthesis in high glucose-treated primary cardiac fibroblasts","volume":"30","author":"Liu","year":"2014","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.004_bib0055","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/jcmm.14800","article-title":"Inhibition of miR-21 alleviated cardiac perivascular fibrosis via repressing EndMT in T1DM","volume":"24","author":"Li","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"15","key":"10.1016\/j.tcm.2022.01.004_bib0056","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.jacc.2020.02.041","article-title":"AntimiR-21 prevents myocardial dysfunction in a pig model of ischemia\/reperfusion injury","volume":"75","author":"Hinkel","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2022.01.004_bib0057","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fcvm.2019.00045","article-title":"Transgenic expression of miR-133a in the diabetic akita heart prevents cardiac remodeling and cardiomyopathy","volume":"6","author":"Kambis","year":"2019","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.tcm.2022.01.004_bib0058","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.108.182535","article-title":"miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling","volume":"104","author":"Duisters","year":"2009","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.tcm.2022.01.004_bib0059","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/jcmm.12218","article-title":"Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes","volume":"18","author":"Chen","year":"2014","journal-title":"J Cell Mol Med"},{"issue":"7","key":"10.1016\/j.tcm.2022.01.004_bib0060","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41418-017-0047-6","article-title":"Diabetes induces the activation of pro-ageing miR-34a in the heart, but has differential effects on cardiomyocytes and cardiac progenitor cells","volume":"25","author":"Fomison-Nurse","year":"2018","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.tcm.2022.01.004_bib0061","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature11919","article-title":"MicroRNA-34a regulates cardiac ageing and function","volume":"495","author":"Boon","year":"2013","journal-title":"Nature"},{"issue":"43","key":"10.1016\/j.tcm.2022.01.004_bib0062","doi-asserted-by":"crossref","first-page":"17615","DOI":"10.1073\/pnas.1206432109","article-title":"Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function","volume":"109","author":"Bernardo","year":"2012","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.tcm.2022.01.004_bib0063","article-title":"Resveratrol pretreatment improved heart recovery ability of hyperglycemic bone marrow stem cells transplantation in diabetic myocardial infarction by down-regulating MicroRNA-34a","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.tcm.2022.01.004_bib0064","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1172\/JCI118742","article-title":"Mechanism of free fatty acid-induced insulin resistance in humans","volume":"97","author":"Roden","year":"1996","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.tcm.2022.01.004_bib0065","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCRESAHA.116.304707","article-title":"MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1\/AMPK pathway","volume":"116","author":"Kuwabara","year":"2015","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.tcm.2022.01.004_bib0066","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/CIRCRESAHA.119.314898","article-title":"Nuclear miR-320 mediates diabetes-induced cardiac dysfunction by activating transcription of fatty acid metabolic genes to cause lipotoxicity in the heart","volume":"125","author":"Li","year":"2019","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.tcm.2022.01.004_bib0067","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12933-019-0811-7","article-title":"MiR-30c\/PGC-1\u03b2 protects against diabetic cardiomyopathy via PPAR\u03b1","volume":"18","author":"Yin","year":"2019","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.tcm.2022.01.004_bib0068","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nbt.3765","article-title":"The chemical evolution of oligonucleotide therapies of clinical utility","volume":"35","author":"Khvorova","year":"2017","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/j.tcm.2022.01.004_bib0069","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.nano.2017.12.004","article-title":"Delivery of microRNA-1 inhibitor by dendrimer-based nanovector: an early targeting therapy for myocardial infarction in mice","volume":"14","author":"Xue","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.tcm.2022.01.004_bib0070","article-title":"MicroRNA sequence codes for small extracellular vesicle release and cellular retention","author":"Garcia-Martin","year":"2021","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.tcm.2022.01.004_bib0071","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa2003608","article-title":"A Novel Circulating MicroRNA for the Detection of Acute Myocarditis","volume":"384","author":"Blanco-Dom\u00ednguez","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173822000068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173822000068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T05:02:07Z","timestamp":1760936527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173822000068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1050173822000068"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2022.01.004","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-mediated control of myocardial infarction in diabetes","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2022.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}